On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Renal Research Institute

InstitutionResearch output, impact & collaborations

Renal Research Institute is a institution indexed in ScholarIQ from OpenAlex.

What is known about Renal Research Institute?

ScholarIQrecord summary

Renal Research Institute is a research organisation in New York, US. OpenAlex records 2,091 works and 188,268 citations for it. 346 researchers list it as their most recent affiliation.

How many works does Renal Research Institute have?

ScholarIQindexed works

Renal Research Institute has 2,091 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Renal Research Institute have?

ScholarIQcitation count

Renal Research Institute has 188,268 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Renal Research Institute?

ScholarIQresearcher count

Renal Research Institute has 346 researchers in the ScholarIQ index.

What is the average h-index at Renal Research Institute?

ScholarIQavg h-index

Renal Research Institute has an average h-index of 54.3 in OpenAlex.

What is the ROR of Renal Research Institute?

ScholarIQror

The ROR for Renal Research Institute is on the source record.

What is the OpenAlex record for Renal Research Institute?

ScholarIQopenalex

The OpenAlex for Renal Research Institute is on the source record.

Who are the most-cited researchers behind Renal Research Institute?

ScholarIQtop researchers by citations
1
Nathan W. Levin · Dialysis and Renal Disease Management
820 works46,894 citations
2
Frank A. Gotch · Dialysis and Renal Disease Management
169 works20,997 citations
3
Len A. Usvyat · Dialysis and Renal Disease Management
384 works3,908 citations

What are the most-cited papers on Renal Research Institute?

ScholarIQmost cited works
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
Garabed Eknoyan, Gerald J. Beck, Alfred K. Cheung, John T. Daugirdas, Tom Greene, John W. Kusek, Michael Allon, James L. Bailey, James A. Delmez, Thomas A. Depner, Johanna Dwyer, Andrew S. Levey, Nathan W. Levin, Edgar L. Milford, Daniel B. Ornt, Michael V. Rocco, Gerald Schulman, Steve J. Schwab, Brendan P. Teehan, Robert D. Toto
New England Journal of Medicine. 20021,879 CitationsOPEN ACCESS
Bone metabolism and disease in chronic kidney disease
Garabed Eknoyan, Adeera Levin, Nathan W. Levin
American Journal of Kidney Diseases. 20031,284 Citations
International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology
Ravindra L. Mehta, Jorge Cerdá, Emmanuel A. Burdmann, Marcello Tonelli, Guillermo García-García, Vivekanand Jha, Paweena Susantitaphong, Michael V. Rocco, Raymond Vanholder, Mehmet Şükrü Sever, Dinna N. Cruz, Bertrand L. Jaber, Norbert Lameire, Raúl Lombardi, Andrew Lewington, John Feehally, Fredric O. Finkelstein, Nathan W. Levin, Neesh Pannu, Bernadette Thomas, Eliah Aronoff‐Spencer, Giuseppe Remuzzi
The Lancet. 20151,151 Citations
Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS
Rajiv Saran, J.L. Bragg-Gresham, Nathan W. Levin, Zbylut J. Twardowski, V. Wizemann, Akira Saitō, Naoki Kimata, Brenda W. Gillespie, Christian Combe, J. Bommer, T. Akiba, Donna Mapes, Eric W. Young, Friedrich K. Port
Kidney International. 2006552 Citations
Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study
Ravindra L. Mehta, Emmanuel A. Burdmann, Jorge Cerdá, John Feehally, Fredric Finkelstein, Guillermo García-García, Mélanie Godin, Vivekanand Jha, Norbert Lameire, Nathan W. Levin, Andrew Lewington, Raúl Lombardi, Etienne Macedo, Michael V. Rocco, Eliah Aronoff‐Spencer, Marcello Tonelli, Jing Zhang, Giuseppe Remuzzi
The Lancet. 2016446 Citations

How much of the research on Renal Research Institute is open access?

ScholarIQopen access share
42%OPEN ACCESS
Gold
0%
Green
8%
Hybrid
8%
Bronze
25%
Closed
58%

Related on ScholarIQ

470M+ articles · 14-day free trial